Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 946

1.

Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.

Parez N, Fourgeux C, Mohamed A, Dubuquoy C, Pillot M, Dehee A, Charpilienne A, Poncet D, Schwartz-Cornil I, Garbarg-Chenon A.

J Virol. 2006 Feb;80(4):1752-61.

2.

The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.

Choi AH, McNeal MM, Flint JA, Basu M, Lycke NY, Clements JD, Bean JA, Davis HL, McCluskie MJ, VanCott JL, Ward RL.

Vaccine. 2002 Mar 15;20(13-14):1733-40.

PMID:
11906760
3.
4.

Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge.

McNeal MM, Basu M, Bean JA, Clements JD, Lycke NY, Ramne A, Löwenadler B, Choi AH, Ward RL.

Vaccine. 2007 Aug 14;25(33):6224-31. Epub 2007 Jun 21.

PMID:
17629371
5.

Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA.

McNeal MM, Stone SC, Basu M, Bean JA, Clements JD, Hendrickson BA, Choi AH, Ward RL.

Virology. 2006 Mar 15;346(2):338-47. Epub 2006 Jan 10.

7.
8.

Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.

García-Díaz A, López-Andújar P, Rodríguez Díaz J, Montava R, Torres Barceló C, Ribes JM, Buesa J.

Vaccine. 2004 Dec 9;23(4):489-98.

PMID:
15530697
9.

Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs.

Nguyen TV, Iosef C, Jeong K, Kim Y, Chang KO, Lovgren-Bengtsson K, Morein B, Azevedo MS, Lewis P, Nielsen P, Yuan L, Saif LJ.

Vaccine. 2003 Sep 8;21(25-26):4059-70.

PMID:
12922143
10.

Development of a Bacillus subtilis-based rotavirus vaccine.

Lee S, Belitsky BR, Brinker JP, Kerstein KO, Brown DW, Clements JD, Keusch GT, Tzipori S, Sonenshein AL, Herrmann JE.

Clin Vaccine Immunol. 2010 Nov;17(11):1647-55. doi: 10.1128/CVI.00135-10. Epub 2010 Sep 1.

11.
12.
13.

Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.

Choi AH, McNeal MM, Basu M, Flint JA, Stone SC, Clements JD, Bean JA, Poe SA, VanCott JL, Ward RL.

Vaccine. 2002 Sep 10;20(27-28):3310-21.

PMID:
12213401
16.

Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice.

Shuttleworth G, Eckery DC, Awram P.

Arch Virol. 2005 Feb;150(2):341-9. Epub 2004 Dec 3.

PMID:
15578236
18.
20.

Different profile and distribution of antigen specific T cells induced by intranasal and intrarectal immunization with rotavirus 2/6-VLP with and without LT-R192G.

Alkadah A, Thiam F, Mounier M, Charpilienne A, Poncet D, Kohli E, Basset C.

Vaccine. 2013 Apr 8;31(15):1924-30. doi: 10.1016/j.vaccine.2013.02.019. Epub 2013 Feb 20.

PMID:
23453731

Supplemental Content

Support Center